The market expects Icon PLC (ICLR) to deliver a year-over-year decline in earnings on lower revenues when it reports results for the quarter ended December 2024. This widely-known consensus outlook is ...

Clinical research conductor ICON Plc downplayed impacts from demand softness from the pharmaceutical and biotechnology industries, surprising investors with a $100 million revenue shortfall that led ...

ICLR was down by 9.12 percent at $198.10 in the pre-market trade on the Nasdaq. Icon PLCShs NewsMORE Related Stocks Indices Commodities Currencies Stocks ...